Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Depreciation & Amortization (D&A) | $34.0K | $12.9M | $3,369.0K | $406.0K | $1,043.0K | $707.0K | $54.0K | $343.0K | $561.0K | $680.0K | $1,073.0K | $1,982.0K | $2,438.0K | $2,901.0K | $4,826.0K | $10.2M | $14.2M | $14.2M | $10.3M | $10.6M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Insmed Incorporated's last 12-month Depreciation & Amortization (D&A) is $11.0M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Insmed Incorporated's Depreciation & Amortization (D&A) growth was 4.1%. The average annual Depreciation & Amortization (D&A) growth rates for Insmed Incorporated have been (8.6%) over the past three years, 1.6% over the past five years.
Over the last year, Insmed Incorporated's Depreciation & Amortization (D&A) growth was 4.1%, which is higher than industry growth of (0.2%). It indicates that Insmed Incorporated's Depreciation & Amortization (D&A) growth is Good.